Sarah Lilley
Brighton, ENG BN19QJ, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Optimisation of a novel series of ENaC inhibitors, leading to the selection of the long-acting inhaled clinical candidate ETD001, a potential new treatment for cystic fibrosis.
Journal: European journal of medicinal chemistry
Published: August 15, 2024
The Tmem16a chloride channel is required for mucin maturation after secretion from goblet-like cells in the Xenopus tropicalis tadpole skin.
Journal: Scientific reports
Published: February 26, 2024
ETD001: A novel inhaled ENaC blocker with an extended duration of action in vivo.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: February 05, 2024
Niclosamide does not modulate airway epithelial function through blocking of the calcium activated chloride channel, TMEM16A.
Journal: Frontiers in pharmacology
Published: January 11, 2023
TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis.
Journal: American journal of respiratory and critical care medicine
Published: January 04, 2020
Family structure and sexual and reproductive health outcomes among adolescents in rural Sierra Leone.
Journal: Global public health
Published: April 17, 2015
Variomics screen identifies the re-entrant loop of the calcium-activated chloride channel ANO1 that facilitates channel activation.
Journal: The Journal of biological chemistry
Published: November 27, 2014
Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 23, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026